Group One Trading’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45,300
| Closed | -$2.34M | – | 8497 |
|
|
2022
Q3 | $2.34M | Buy |
45,300
+7,700
| +20% | +$318K | ﹤0.01% | 1775 |
|
|
2022
Q2 | $932K | Sell |
37,600
-52,400
| -58% | -$1.15M | ﹤0.01% | 2821 |
|
|
2022
Q1 | $2.26M | Sell |
90,000
-1,000
| -1% | -$28.1K | ﹤0.01% | 2282 |
|
|
2021
Q4 | $3.31M | Sell |
91,000
-310,600
| -77% | -$10.9M | ﹤0.01% | 2079 |
|
|
2021
Q3 | $6.87M | Buy |
401,600
+223,000
| +125% | +$3.47M | 0.01% | 1399 |
|
|
2021
Q2 | $2.39M | Buy |
178,600
+159,200
| +821% | +$3.92M | ﹤0.01% | 2450 |
|
|
2021
Q1 | $994K | Buy |
19,400
+17,300
| +824% | +$1.04M | ﹤0.01% | 3233 |
|
|
2020
Q4 | $130K | Sell |
2,100
-35,200
| -94% | -$2.02M | ﹤0.01% | 4380 |
|
|
2020
Q3 | $2.04M | Buy |
37,300
+24,200
| +185% | +$1.3M | 0.01% | 1578 |
|
|
2020
Q2 | $754K | Sell |
13,100
-79,400
| -86% | -$4.32M | ﹤0.01% | 2293 |
|
|
2020
Q1 | $3.72M | Sell |
92,500
-46,900
| -34% | -$1.99M | 0.03% | 688 |
|
|
2019
Q4 | $5.51M | Buy |
139,400
+108,500
| +351% | +$1.91M | 0.04% | 622 |
|
|
2019
Q3 | $210K | Buy |
30,900
+16,600
| +116% | +$125K | ﹤0.01% | 3040 |
|
|
2019
Q2 | $133K | Sell |
14,300
-9,400
| -40% | -$109K | ﹤0.01% | 3133 |
|
|
2019
Q1 | $329K | Buy |
23,700
+2,700
| +13% | +$30.9K | ﹤0.01% | 2293 |
|
|
2018
Q4 | $229K | Sell |
21,000
-8,800
| -30% | -$92.8K | ﹤0.01% | 2581 |
|
|
2018
Q3 | $377K | Buy |
29,800
+16,000
| +116% | +$193K | ﹤0.01% | 2520 |
|
|
2018
Q2 | $182K | Buy |
13,800
+4,800
| +53% | +$57.4K | ﹤0.01% | 3123 |
|
|
2018
Q1 | $122K | Buy |
+9,000
| New | +$92.9K | ﹤0.01% | 3127 |
|
|
2017
Q3 | – | Sell |
-11,000
| Closed | -$103K | – | 5310 |
|
|
2017
Q2 | $103K | Sell |
11,000
-1,000
| -8% | -$7.34K | ﹤0.01% | 3084 |
|
|
2017
Q1 | $87K | Buy |
12,000
+6,000
| +100% | +$43.2K | ﹤0.01% | 3064 |
|
|
2016
Q4 | $44K | Buy |
6,000
+2,000
| +50% | +$14.4K | ﹤0.01% | 3330 |
|
|
2016
Q3 | $24K | Buy |
+4,000
| New | +$18.9K | ﹤0.01% | 3720 |
|
|
2016
Q1 | – | Sell |
-10,000
| Closed | -$81K | – | 5099 |
|
|
2015
Q4 | $81K | Sell |
10,000
-4,000
| -29% | -$28.3K | ﹤0.01% | 3121 |
|
|
2015
Q3 | $85K | Hold |
14,000
| – | – | ﹤0.01% | 3161 |
|
|
2015
Q2 | $115K | Buy |
14,000
+3,900
| +39% | +$31K | ﹤0.01% | 2971 |
|
|
2015
Q1 | $76K | Buy |
10,100
+2,300
| +29% | +$18K | ﹤0.01% | 3086 |
|
|
2014
Q4 | $53K | Sell |
7,800
-7,600
| -49% | -$40.2K | ﹤0.01% | 3336 |
|
|
2014
Q3 | $69K | Hold |
15,400
| – | – | ﹤0.01% | 3310 |
|
|
2014
Q2 | $90K | Buy |
15,400
+8,000
| +108% | +$44.9K | ﹤0.01% | 3093 |
|
|
2014
Q1 | $49K | Sell |
7,400
-6,100
| -45% | -$42.4K | ﹤0.01% | 3647 |
|
|
2013
Q4 | $78K | Buy |
13,500
+3,600
| +36% | +$18.6K | ﹤0.01% | 3262 |
|
|
2013
Q3 | $55K | Buy |
+9,900
| New | +$107K | ﹤0.01% | 3473 |
|
Other funds holding CCXI
Group One Trading's CCXI Position: Q3 2022 in Review
Group One Trading sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 80,635 shares — an estimated $3.33M sold.
Group One Trading first reported a position in CCXI in Q4 2013 and held it in 18 quarters. The position peaked at $4.47M in Q3 2021. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.
- Group One Trading reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
- Group One Trading sold 80,635 ChemoCentryx, Inc. shares in Q3 2022, an estimated $3.33M.
- Group One Trading first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 18 quarters.
- Group One Trading's ChemoCentryx, Inc. position peaked at $4.47M in Q3 2021.
- 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.
Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.